(MedPage Today) -- Children with chronic autoimmune uveitis showed favorable responses to treatment with either adalimumab (Humira) or infliximab (Remicade), although not with etanercept (Enbrel), a meta-analysis found. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment